Role of epstein-barr virus in the severity of recurrent respiratory papillomatosis
- PMID: 31860132
- DOI: 10.1002/lary.28465
Role of epstein-barr virus in the severity of recurrent respiratory papillomatosis
Abstract
Objective: The objective was to investigate the prevalence of the Epstein-Barr virus (EBV) and its association with human papilloma virus (HPV) detection, clinicopathological features, and the severity of recurrent respiratory papillomatosis (RRP).
Methods: Cases of juvenile recurrent respiratory papillomatosis (JRRP) (n = 36) and adult recurrent respiratory papillomatosis (ARRP) (n = 44) were collected retrospectively and subdivided into low- and high-risk severity groups based on the Derkay score. We performed HPV detection and genotyping using a reverse hybridization protocol and investigated the presence of EBV by polymerase chain reaction (PCR) and in situ hybridization. CD21 levels were accessed by immunohistochemistry.
Results: All samples were HPV-positive, including 49 cases of HPV 6, 26 cases of HPV 11, four cases of HPV 6 and 11 coinfections, and one case of HPV 16. EBV-DNA was detected in nine samples by PCR, although none of the cases were positive by means of in situ hybridization. CD21 immunoexpression was not statistically associated with any of the variables analyzed. HPV 6 detection was significantly higher in ARRP cases (P = 0.03), whereas HPV 11 was more prevalent in JRRP cases (P = 0.02) and was even more prevalent in JRRP cases of greater severity (Derkay laryngoscopic scale ≥20) (P = 0.04).
Conclusion: The presence of EBV does not seem to play an important role in the progression/severity of RRP.
Level of evidence: 4 Laryngoscope, 130:E611-E618, 2020.
Keywords: CD21; Epstein-Barr virus; Squamous papillomatosis; human papilloma virus; severity.
© 2019 The American Laryngological, Rhinological and Otological Society, Inc.
Similar articles
-
Prevalence of Epstein-Barr virus infection in recurrent respiratory papillomatosis and the influence on disease severity.Diagn Microbiol Infect Dis. 2022 May;103(1):115655. doi: 10.1016/j.diagmicrobio.2022.115655. Epub 2022 Feb 3. Diagn Microbiol Infect Dis. 2022. PMID: 35228131
-
Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.J Oral Pathol Med. 2015 Jan;44(1):28-36. doi: 10.1111/jop.12221. Epub 2014 Jul 18. J Oral Pathol Med. 2015. PMID: 25040496 Free PMC article.
-
Human papillomavirus and Epstein-Barr virus in sinonasal Schneiderian papillomas. An in situ hybridization and polymerase chain reaction study.Am J Clin Pathol. 1996 Oct;106(4):475-82. doi: 10.1093/ajcp/106.4.475. Am J Clin Pathol. 1996. PMID: 8853035
-
Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.Laryngoscope. 2004 Nov;114(11 Pt 2 Suppl 104):1-23. doi: 10.1097/01.mlg.000148224.83491.0f. Laryngoscope. 2004. PMID: 15514560 Review.
-
How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis.Laryngoscope. 2021 Sep;131(9):2041-2047. doi: 10.1002/lary.29153. Epub 2021 Mar 15. Laryngoscope. 2021. PMID: 33720393 Free PMC article. Review.
Cited by
-
Chinese guideline for the diagnosis and treatment of juvenile-onset recurrent respiratory papillomatosis (2024).Pediatr Investig. 2025 Mar 17;9(1):12-34. doi: 10.1002/ped4.12464. eCollection 2025 Mar. Pediatr Investig. 2025. PMID: 40241885 Free PMC article.
-
HPV-Associated Benign Squamous Cell Papillomas in the Upper Aero-Digestive Tract and Their Malignant Potential.Viruses. 2021 Aug 17;13(8):1624. doi: 10.3390/v13081624. Viruses. 2021. PMID: 34452488 Free PMC article. Review.
-
Clinical implications of alpha, beta, and gamma HPV infection in juvenile onset recurrent respiratory papillomatosis.Eur Arch Otorhinolaryngol. 2022 Jan;279(1):285-292. doi: 10.1007/s00405-021-07040-9. Epub 2021 Aug 28. Eur Arch Otorhinolaryngol. 2022. PMID: 34453571 Free PMC article.
-
"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis".Respir Res. 2024 Dec 18;25(1):430. doi: 10.1186/s12931-024-03057-w. Respir Res. 2024. PMID: 39696284 Free PMC article.
References
BIBLIOGRAPHY
-
- Aaltonen LM, Rihkanen H, Vaheri A. Human papillomavirus in larynx. Laryngoscope 2002;112:700-707.
-
- Richardson M, Gale N, Hille J, Zidar N. Tumours of the hypopharynx, larynx, trachea and parapharyngeal space. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO Classification of Head and Neck Tumours. 4th ed. Lyon, France: IARC; 2017:93-95.
-
- Auborn KJ, Little RD, Platt TH, Vaccariello MA, Schildkraut CL. Replicative intermediates of human papillomavirus type 11 in laryngeal papillomas: site of replication initiation and direction of replication. Proc Natl Acad Sci U S A 1994;91:7340-7344.
-
- Vancurova I, Wu R, Miskolci V, Sun S. Increased p50/p50 NF-kappaB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue. J Virol 2002;76:1533-1536.
-
- Donne AJ, Hampson L, Homer JJ, Hampson IN. The role of HPV type in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2010;74:7-14.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials